81 FR 7819 - Advisory Commission on Childhood Vaccines; Notice of Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration Federal Register Volume 81, Issue 30 (February 16, 2016)
Health Resources and Services Administration
Federal Register Volume 81, Issue 30 (February 16, 2016)
| Page Range | 7819-7819 | |
| FR Document | 2016-03015 |
[Federal Register Volume 81, Number 30 (Tuesday, February 16, 2016)] [Notices] [Page 7819] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-03015] [[Page 7819]] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Commission on Childhood Vaccines; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92-463), notice is hereby given of the following meeting: Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: March 3, 2016, 10:00 a.m. to 3:15 p.m. EDT. Place: Audio Conference Call and Adobe Connect Pro. The ACCV will meet on Thursday, March 3, 2016, from 10:00 a.m. to 3:15 p.m. (EDT). The public can join the meeting by: 1. (Audio Portion) Calling the conference phone number 1-800-779- 3561 and providing the following information: Leaders Name: Dr. Narayan Nair. Password: 8164763. 2. (Visual Portion) Connecting to the ACCV Adobe Connect Pro Meeting using the following URL: https://hrsa.connectsolutions.com/accv/ (copy and paste the link into your browser if it does not work directly and enter as a guest). Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by following URL: http://www.adobe.com/go/connectpro_overview. Call (301) 443-6634 or send an email to [email protected] if you are having trouble connecting to the meeting site. Agenda: The agenda items for the March 2016 meeting will include, but are not limited to, updates from the Division of Injury Compensation Programs (DICP), Department of Justice (DOJ), National Vaccine Program Office (NVPO), Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health) and Center for Biologics, Evaluation and Research (Food and Drug Administration). A draft agenda and additional meeting materials will be posted on the ACCV Web site (http://www.hrsa.gov/vaccinecompensation/accv.htm) prior to the meeting. Agenda items are subject to change as priorities dictate. Public Comment: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Annie Herzog, DICP, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 8N146B, 5600 Fishers Lane, Rockville, Maryland 20857 or email: [email protected]. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DICP will notify each presenter by email, mail, or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the public comment period. Public participation and ability to comment will be limited to space and time as it permits. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the contact person listed below at least 10 days prior to the meeting. FOR FURTHER INFORMATION CONTACT: Anyone requiring information regarding the ACCV should contact Annie Herzog, DICP, HSB, HRSA, Room 8N146B, 5600 Fishers Lane, Rockville, Maryland 20857; telephone (301) 443-6593, or email: [email protected]. Jackie Painter, Director, Division of the Executive Secretariat. [FR Doc. 2016-03015 Filed 2-12-16; 8:45 am] BILLING CODE 4165-15-P
![Federal Register / Vol. 81, No. 30 / Tuesday, February 16, 2016 / Notices 7819
DEPARTMENT OF HEALTH AND Public Comment: Persons interested individuals associated with the grant
HUMAN SERVICES in providing an oral presentation should applications, the disclosure of which
submit a written request, along with a would constitute a clearly unwarranted
Health Resources and Services copy of their presentation to: Annie invasion of personal privacy.
Administration Herzog, DICP, Healthcare Systems Name of Committee: Center for Scientific
Bureau (HSB), Health Resources and Review Special Emphasis Panel; Member
Advisory Commission on Childhood Services Administration (HRSA), Room
Vaccines; Notice of Meeting Conflict: Biological Chemistry and
8N146B, 5600 Fishers Lane, Rockville, Macromolecular Biophysics.
In accordance with section 10(a)(2) of Maryland 20857 or email: aherzog@ Date: March 1, 2016.
the Federal Advisory Committee Act hrsa.gov. Requests should contain the Time: 3:00 p.m. to 5:00 p.m.
(Public Law 92–463), notice is hereby name, address, telephone number, email Agenda: To review and evaluate grant
given of the following meeting: address, and any business or applications.
Name: Advisory Commission on professional affiliation of the person Place: National Institutes of Health, 6701
Childhood Vaccines (ACCV). desiring to make an oral presentation. Rockledge Drive, Bethesda, MD 20892
Date and Time: March 3, 2016, 10:00 Groups having similar interests are (Telephone Conference Call).
a.m. to 3:15 p.m. EDT. requested to combine their comments Contact Person: David R Jollie, Ph.D.,
Place: Audio Conference Call and and present them through a single Scientific Review Officer, Center for
Adobe Connect Pro. representative. The allocation of time Scientific Review, National Institutes of
The ACCV will meet on Thursday, may be adjusted to accommodate the Health, 6701 Rockledge Drive, Room 4150,
March 3, 2016, from 10:00 a.m. to 3:15 level of expressed interest. DICP will MSC 7806, Bethesda, MD 20892, (301)–435–
notify each presenter by email, mail, or 1722, jollieda@csr.nih.gov.
p.m. (EDT). The public can join the
telephone of their assigned presentation Name of Committee: Center for Scientific
meeting by:
time. Persons who do not file an Review Special Emphasis Panel; PAR Panel:
1. (Audio Portion) Calling the
advance request for a presentation, but Investigations on Primary Immunodeficiency
conference phone number 1–800–779–
desire to make an oral statement, may Diseases.
3561 and providing the following
announce it at the time of the public Date: March 3, 2016.
information:
comment period. Public participation Time: 1:00 p.m. to 4:00 p.m.
Leaders Name: Dr. Narayan Nair.
and ability to comment will be limited Agenda: To review and evaluate grant
Password: 8164763.
to space and time as it permits. applications.
2. (Visual Portion) Connecting to the
Individuals who plan to attend and Place: National Institutes of Health, 6701
ACCV Adobe Connect Pro Meeting
need special assistance, such as sign Rockledge Drive, Bethesda, MD 20892
using the following URL: https://
language interpretation or other (Virtual Meeting).
hrsa.connectsolutions.com/accv/ (copy
reasonable accommodations, should Contact Person: Jin Huang, Ph.D.,
and paste the link into your browser if
notify the contact person listed below at Scientific Review Officer, Center for
it does not work directly and enter as a least 10 days prior to the meeting. Scientific Review, National Institutes of
guest). Participants should call and Health, 6701 Rockledge Drive, Room 4095G,
FOR FURTHER INFORMATION CONTACT:
connect 15 minutes prior to the meeting MSC 7812, Bethesda, MD 20892, 301–435–
in order for logistics to be set up. If you Anyone requiring information regarding
the ACCV should contact Annie Herzog, 1230, jh377p@nih.gov.
have never attended an Adobe Connect
DICP, HSB, HRSA, Room 8N146B, 5600 Name of Committee: Center for Scientific
meeting, please test your connection
Fishers Lane, Rockville, Maryland Review Special Emphasis Panel; PAR
using the following URL: https://
20857; telephone (301) 443–6593, or Review: Synthetic Psychoactive Drugs and
hrsa.connectsolutions.com/common/
email: aherzog@hrsa.gov. Strategic Approaches to Counteract Their
help/en/support/meeting_test.htm and Deleterious Effects.
get a quick overview by following URL: Jackie Painter, Date: March 4, 2016.
http://www.adobe.com/go/connectpro_ Director, Division of the Executive Secretariat. Time: 11:00 a.m. to 1:30 p.m.
overview. Call (301) 443–6634 or send [FR Doc. 2016–03015 Filed 2–12–16; 8:45 am] Agenda: To review and evaluate grant
an email to aherzog@hrsa.gov if you are BILLING CODE 4165–15–P applications.
having trouble connecting to the Place: National Institutes of Health, 6701
meeting site. Rockledge Drive, Bethesda, MD 20892
Agenda: The agenda items for the DEPARTMENT OF HEALTH AND (Telephone Conference Call).
March 2016 meeting will include, but HUMAN SERVICES Contact Person: Nicholas Gaiano, Ph.D.,
are not limited to, updates from the Scientific Review Officer, Center for
Division of Injury Compensation National Institutes of Health Scientific Review, National Institutes of
Programs (DICP), Department of Justice Health, 6701 Rockledge Drive, Room 5178,
(DOJ), National Vaccine Program Office Center for Scientific Review; Notice of MSC 7844, Bethesda, MD 20892–7844, 301–
(NVPO), Immunization Safety Office Closed Meetings 435–1033, gaianonr@csr.nih.gov.
(Centers for Disease Control and Pursuant to section 10(d) of the (Catalogue of Federal Domestic Assistance
Prevention), National Institute of Federal Advisory Committee Act, as Program Nos. 93.306, Comparative Medicine;
Allergy and Infectious Diseases amended (5 U.S.C. App.), notice is 93.333, Clinical Research, 93.306, 93.333,
(National Institutes of Health) and hereby given of the following meetings. 93.337, 93.393–93.396, 93.837–93.844,
Center for Biologics, Evaluation and The meetings will be closed to the 93.846–93.878, 93.892, 93.893, National
mstockstill on DSK4VPTVN1PROD with NOTICES
Research (Food and Drug public in accordance with the Institutes of Health, HHS)
Administration). A draft agenda and provisions set forth in sections
Dated: February 9, 2016.
additional meeting materials will be 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
posted on the ACCV Web site (http:// as amended. The grant applications and Natasha M. Copeland,
www.hrsa.gov/vaccinecompensation/ the discussions could disclose Program Analyst, Office of Federal Advisory
accv.htm) prior to the meeting. Agenda confidential trade secrets or commercial Committee Policy.
items are subject to change as priorities property such as patentable material, [FR Doc. 2016–02972 Filed 2–12–16; 8:45 am]
dictate. and personal information concerning BILLING CODE 4140–01–P
VerDate Sep<11>2014 22:15 Feb 12, 2016 Jkt 238001 PO 00000 Frm 00078 Fmt 4703 Sfmt 9990 E:\FR\FM\16FEN1.SGM 16FEN1](https://thefederalregister.org/doc/81_FR_7849/page/1.svg)
Document Created: 2016-02-13 03:13:46
Document Modified: 2016-02-13 03:13:46
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Contact | Anyone requiring information regarding the ACCV should contact Annie Herzog, DICP, HSB, HRSA, Room 8N146B, 5600 Fishers Lane, Rockville, Maryland 20857; telephone (301) 443-6593, or email: [email protected] | |
| FR Citation | 81 FR 7819 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR